Welcome to Health Care POV | sign in | join
in Search

BROWSE BY TAGS

All Tags » NP Entrepreneur... » General Interes... » Prescribing » Business
  • Healthy Competition

    First there was Botox, then there was Dysport, and now there is Xeomin (incobotulinumtoxinA). Xeomin is the latest addition to a growing list of botulinum toxin type A injectables. The Food and Drug Administration recently approved this new botulinum product to treat severe frown lines between the eyebrows, and I'm anxiously waiting for its ...
    Posted to Aesthetics Practice Today (Weblog) on November 8, 2011